2012/13 influenza vaccine effectiveness against hospitalised influenza A(H1N1)pdm09, A(H3N2) and B: estimates from a European network of hospitals.
Identifieur interne : 000117 ( Hal/Checkpoint ); précédent : 000116; suivant : 0001182012/13 influenza vaccine effectiveness against hospitalised influenza A(H1N1)pdm09, A(H3N2) and B: estimates from a European network of hospitals.
Auteurs : M. Rondy [France] ; O. Launay [France] ; J. Puig-Barberà ; G. Gefenaite ; J. Castilla ; K. De Gaetano Donati ; F. Galtier [France] ; E. Hak ; M. Guevara ; S. Costanzo ; A. Moren [France]Source :
- Eurosurveillance [ 1560-7917 ] ; 2015-01-15.
Abstract
While influenza vaccines aim to decrease the incidence of severe influenza among high-risk groups, evidence of influenza vaccine effectiveness (IVE) among the influenza vaccine target population is sparse. We conducted a multicentre test-negative case-control study to estimate IVE against hospitalised laboratory-confirmed influenza in the target population in 18 hospitals in France, Italy, Lithuania and the Navarre and Valencia regions in Spain. All hospitalised patients aged ≥18 years, belonging to the target population presenting with influenza-like illness symptom onset within seven days were swabbed. Patients positive by reverse transcription polymerase chain reaction for influenza virus were cases and those negative were controls. Using logistic regression, we calculated IVE for each influenza virus subtype and adjusted it for month of symptom onset, study site, age and chronic conditions. Of the 1,972 patients included, 116 were positive for influenza A(H1N1)pdm09, 58 for A(H3N2) and 232 for influenza B. Adjusted IVE was 21.3% (95% confidence interval (CI): -25.2 to 50.6; n=1,628), 61.8% (95% CI: 26.8 to 80.0; n=557) and 43.1% (95% CI: 21.2 to 58.9; n=1,526) against influenza A(H1N1) pdm09, A(H3N2) and B respectively. Our results suggest that the 2012/13 IVE was moderate against influenza A(H3N2) and B and low against influenza A(H1N1) pdm09.
Url:
Links toward previous steps (curation, corpus...)
Links to Exploration step
Hal:hal-01990891Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">2012/13 influenza vaccine effectiveness against hospitalised influenza A(H1N1)pdm09, A(H3N2) and B: estimates from a European network of hospitals.</title><author><name sortKey="Rondy, M" sort="Rondy, M" uniqKey="Rondy M" first="M" last="Rondy">M. Rondy</name><affiliation wicri:level="1"><hal:affiliation type="institution" xml:id="struct-534644" status="INCOMING"> <orgName>EpiConcept [Paris]</orgName> <desc> <address> <addrLine>Paris.</addrLine> <country key="FR"></country> </address> </desc> </hal:affiliation><country>France</country></affiliation></author><author><name sortKey="Launay, O" sort="Launay, O" uniqKey="Launay O" first="O." last="Launay">O. Launay</name><affiliation wicri:level="1"><hal:affiliation type="laboratory" xml:id="struct-232778" status="INCOMING"> <orgName>REseau national d'Investigation clinique en VACcinologie</orgName> <orgName type="acronym">REIVAC</orgName> <desc> <address> <addrLine>Bâtiment Lavoisier - 27, rue du Faubourg Saint Jacques - 75014 PARIS</addrLine> <country key="FR"></country> </address> </desc> <listRelation> <relation active="#struct-356457" type="direct"></relation> <relation active="#struct-303623" type="direct"></relation> <relation active="#struct-302361" type="direct"></relation> <relation active="#struct-300142" type="direct"></relation> <relation active="#struct-300123" type="direct"></relation> <relation active="#struct-300068" type="direct"></relation> </listRelation> <tutelles><tutelle active="#struct-356457" type="direct"><org type="institution" xml:id="struct-356457" status="INCOMING"> <orgName>Centre National de Gestion des Essais de Produits de Santé (CeNGEPS)</orgName> <desc> <address> <country key="FR"></country> </address> </desc> </org></tutelle><tutelle active="#struct-303623" type="direct"><org type="institution" xml:id="struct-303623" status="VALID"> <idno type="IdRef">026388278</idno> <orgName>Institut National de la Santé et de la Recherche Médicale</orgName> <orgName type="acronym">INSERM</orgName> <desc> <address> <addrLine>101, rue de Tolbiac, 75013 Paris </addrLine> <country key="FR"></country> </address> <ref type="url">http://www.inserm.fr</ref> </desc> </org></tutelle><tutelle active="#struct-302361" type="direct"><org type="institution" xml:id="struct-302361" status="VALID"> <orgName>Groupe hospitalier Broca</orgName> <desc> <address> <country key="FR"></country> </address> </desc> </org></tutelle><tutelle active="#struct-300142" type="direct"><org type="institution" xml:id="struct-300142" status="VALID"> <orgName>Hôtel-Dieu</orgName> <desc> <address> <country key="FR"></country> </address> </desc> </org></tutelle><tutelle active="#struct-300123" type="direct"><org type="institution" xml:id="struct-300123" status="VALID"> <orgName>CHU Cochin [AP-HP]</orgName> <desc> <address> <addrLine>27 Rue du Faubourg Saint-Jacques 75014 Paris</addrLine> <country key="FR"></country> </address> </desc> </org></tutelle><tutelle active="#struct-300068" type="direct"><org type="regroupinstitution" xml:id="struct-300068" status="VALID"> <orgName>Assistance publique - Hôpitaux de Paris (AP-HP)</orgName> <orgName type="acronym">APHP</orgName> <desc> <address> <country key="FR"></country> </address> </desc> </org></tutelle></tutelles></hal:affiliation><country>France</country></affiliation></author><author><name sortKey="Puig Barbera, J" sort="Puig Barbera, J" uniqKey="Puig Barbera J" first="J" last="Puig-Barberà">J. Puig-Barberà</name></author><author><name sortKey="Gefenaite, G" sort="Gefenaite, G" uniqKey="Gefenaite G" first="G" last="Gefenaite">G. Gefenaite</name></author><author><name sortKey="Castilla, J" sort="Castilla, J" uniqKey="Castilla J" first="J" last="Castilla">J. Castilla</name></author><author><name sortKey="De Gaetano Donati, K" sort="De Gaetano Donati, K" uniqKey="De Gaetano Donati K" first="K" last="De Gaetano Donati">K. De Gaetano Donati</name></author><author><name sortKey="Galtier, F" sort="Galtier, F" uniqKey="Galtier F" first="F." last="Galtier">F. Galtier</name><affiliation wicri:level="1"><hal:affiliation type="laboratory" xml:id="struct-232778" status="INCOMING"> <orgName>REseau national d'Investigation clinique en VACcinologie</orgName> <orgName type="acronym">REIVAC</orgName> <desc> <address> <addrLine>Bâtiment Lavoisier - 27, rue du Faubourg Saint Jacques - 75014 PARIS</addrLine> <country key="FR"></country> </address> </desc> <listRelation> <relation active="#struct-356457" type="direct"></relation> <relation active="#struct-303623" type="direct"></relation> <relation active="#struct-302361" type="direct"></relation> <relation active="#struct-300142" type="direct"></relation> <relation active="#struct-300123" type="direct"></relation> <relation active="#struct-300068" type="direct"></relation> </listRelation> <tutelles><tutelle active="#struct-356457" type="direct"><org type="institution" xml:id="struct-356457" status="INCOMING"> <orgName>Centre National de Gestion des Essais de Produits de Santé (CeNGEPS)</orgName> <desc> <address> <country key="FR"></country> </address> </desc> </org></tutelle><tutelle active="#struct-303623" type="direct"><org type="institution" xml:id="struct-303623" status="VALID"> <idno type="IdRef">026388278</idno> <orgName>Institut National de la Santé et de la Recherche Médicale</orgName> <orgName type="acronym">INSERM</orgName> <desc> <address> <addrLine>101, rue de Tolbiac, 75013 Paris </addrLine> <country key="FR"></country> </address> <ref type="url">http://www.inserm.fr</ref> </desc> </org></tutelle><tutelle active="#struct-302361" type="direct"><org type="institution" xml:id="struct-302361" status="VALID"> <orgName>Groupe hospitalier Broca</orgName> <desc> <address> <country key="FR"></country> </address> </desc> </org></tutelle><tutelle active="#struct-300142" type="direct"><org type="institution" xml:id="struct-300142" status="VALID"> <orgName>Hôtel-Dieu</orgName> <desc> <address> <country key="FR"></country> </address> </desc> </org></tutelle><tutelle active="#struct-300123" type="direct"><org type="institution" xml:id="struct-300123" status="VALID"> <orgName>CHU Cochin [AP-HP]</orgName> <desc> <address> <addrLine>27 Rue du Faubourg Saint-Jacques 75014 Paris</addrLine> <country key="FR"></country> </address> </desc> </org></tutelle><tutelle active="#struct-300068" type="direct"><org type="regroupinstitution" xml:id="struct-300068" status="VALID"> <orgName>Assistance publique - Hôpitaux de Paris (AP-HP)</orgName> <orgName type="acronym">APHP</orgName> <desc> <address> <country key="FR"></country> </address> </desc> </org></tutelle></tutelles></hal:affiliation><country>France</country></affiliation></author><author><name sortKey="Hak, E" sort="Hak, E" uniqKey="Hak E" first="E" last="Hak">E. Hak</name></author><author><name sortKey="Guevara, M" sort="Guevara, M" uniqKey="Guevara M" first="M." last="Guevara">M. Guevara</name></author><author><name sortKey="Costanzo, S" sort="Costanzo, S" uniqKey="Costanzo S" first="S" last="Costanzo">S. Costanzo</name></author><author><name sortKey="Moren, A" sort="Moren, A" uniqKey="Moren A" first="A" last="Moren">A. Moren</name><affiliation wicri:level="1"><hal:affiliation type="institution" xml:id="struct-534644" status="INCOMING"> <orgName>EpiConcept [Paris]</orgName> <desc> <address> <addrLine>Paris.</addrLine> <country key="FR"></country> </address> </desc> </hal:affiliation><country>France</country></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">HAL</idno><idno type="RBID">Hal:hal-01990891</idno><idno type="halId">hal-01990891</idno><idno type="halUri">https://hal.umontpellier.fr/hal-01990891</idno><idno type="url">https://hal.umontpellier.fr/hal-01990891</idno><date when="2015-01-15">2015-01-15</date><idno type="wicri:Area/Hal/Corpus">000002</idno><idno type="wicri:Area/Hal/Curation">000002</idno><idno type="wicri:Area/Hal/Checkpoint">000117</idno><idno type="wicri:explorRef" wicri:stream="Hal" wicri:step="Checkpoint">000117</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">2012/13 influenza vaccine effectiveness against hospitalised influenza A(H1N1)pdm09, A(H3N2) and B: estimates from a European network of hospitals.</title><author><name sortKey="Rondy, M" sort="Rondy, M" uniqKey="Rondy M" first="M" last="Rondy">M. Rondy</name><affiliation wicri:level="1"><hal:affiliation type="institution" xml:id="struct-534644" status="INCOMING"> <orgName>EpiConcept [Paris]</orgName> <desc> <address> <addrLine>Paris.</addrLine> <country key="FR"></country> </address> </desc> </hal:affiliation><country>France</country></affiliation></author><author><name sortKey="Launay, O" sort="Launay, O" uniqKey="Launay O" first="O." last="Launay">O. Launay</name><affiliation wicri:level="1"><hal:affiliation type="laboratory" xml:id="struct-232778" status="INCOMING"> <orgName>REseau national d'Investigation clinique en VACcinologie</orgName> <orgName type="acronym">REIVAC</orgName> <desc> <address> <addrLine>Bâtiment Lavoisier - 27, rue du Faubourg Saint Jacques - 75014 PARIS</addrLine> <country key="FR"></country> </address> </desc> <listRelation> <relation active="#struct-356457" type="direct"></relation> <relation active="#struct-303623" type="direct"></relation> <relation active="#struct-302361" type="direct"></relation> <relation active="#struct-300142" type="direct"></relation> <relation active="#struct-300123" type="direct"></relation> <relation active="#struct-300068" type="direct"></relation> </listRelation> <tutelles><tutelle active="#struct-356457" type="direct"><org type="institution" xml:id="struct-356457" status="INCOMING"> <orgName>Centre National de Gestion des Essais de Produits de Santé (CeNGEPS)</orgName> <desc> <address> <country key="FR"></country> </address> </desc> </org></tutelle><tutelle active="#struct-303623" type="direct"><org type="institution" xml:id="struct-303623" status="VALID"> <idno type="IdRef">026388278</idno> <orgName>Institut National de la Santé et de la Recherche Médicale</orgName> <orgName type="acronym">INSERM</orgName> <desc> <address> <addrLine>101, rue de Tolbiac, 75013 Paris </addrLine> <country key="FR"></country> </address> <ref type="url">http://www.inserm.fr</ref> </desc> </org></tutelle><tutelle active="#struct-302361" type="direct"><org type="institution" xml:id="struct-302361" status="VALID"> <orgName>Groupe hospitalier Broca</orgName> <desc> <address> <country key="FR"></country> </address> </desc> </org></tutelle><tutelle active="#struct-300142" type="direct"><org type="institution" xml:id="struct-300142" status="VALID"> <orgName>Hôtel-Dieu</orgName> <desc> <address> <country key="FR"></country> </address> </desc> </org></tutelle><tutelle active="#struct-300123" type="direct"><org type="institution" xml:id="struct-300123" status="VALID"> <orgName>CHU Cochin [AP-HP]</orgName> <desc> <address> <addrLine>27 Rue du Faubourg Saint-Jacques 75014 Paris</addrLine> <country key="FR"></country> </address> </desc> </org></tutelle><tutelle active="#struct-300068" type="direct"><org type="regroupinstitution" xml:id="struct-300068" status="VALID"> <orgName>Assistance publique - Hôpitaux de Paris (AP-HP)</orgName> <orgName type="acronym">APHP</orgName> <desc> <address> <country key="FR"></country> </address> </desc> </org></tutelle></tutelles></hal:affiliation><country>France</country></affiliation></author><author><name sortKey="Puig Barbera, J" sort="Puig Barbera, J" uniqKey="Puig Barbera J" first="J" last="Puig-Barberà">J. Puig-Barberà</name></author><author><name sortKey="Gefenaite, G" sort="Gefenaite, G" uniqKey="Gefenaite G" first="G" last="Gefenaite">G. Gefenaite</name></author><author><name sortKey="Castilla, J" sort="Castilla, J" uniqKey="Castilla J" first="J" last="Castilla">J. Castilla</name></author><author><name sortKey="De Gaetano Donati, K" sort="De Gaetano Donati, K" uniqKey="De Gaetano Donati K" first="K" last="De Gaetano Donati">K. De Gaetano Donati</name></author><author><name sortKey="Galtier, F" sort="Galtier, F" uniqKey="Galtier F" first="F." last="Galtier">F. Galtier</name><affiliation wicri:level="1"><hal:affiliation type="laboratory" xml:id="struct-232778" status="INCOMING"> <orgName>REseau national d'Investigation clinique en VACcinologie</orgName> <orgName type="acronym">REIVAC</orgName> <desc> <address> <addrLine>Bâtiment Lavoisier - 27, rue du Faubourg Saint Jacques - 75014 PARIS</addrLine> <country key="FR"></country> </address> </desc> <listRelation> <relation active="#struct-356457" type="direct"></relation> <relation active="#struct-303623" type="direct"></relation> <relation active="#struct-302361" type="direct"></relation> <relation active="#struct-300142" type="direct"></relation> <relation active="#struct-300123" type="direct"></relation> <relation active="#struct-300068" type="direct"></relation> </listRelation> <tutelles><tutelle active="#struct-356457" type="direct"><org type="institution" xml:id="struct-356457" status="INCOMING"> <orgName>Centre National de Gestion des Essais de Produits de Santé (CeNGEPS)</orgName> <desc> <address> <country key="FR"></country> </address> </desc> </org></tutelle><tutelle active="#struct-303623" type="direct"><org type="institution" xml:id="struct-303623" status="VALID"> <idno type="IdRef">026388278</idno> <orgName>Institut National de la Santé et de la Recherche Médicale</orgName> <orgName type="acronym">INSERM</orgName> <desc> <address> <addrLine>101, rue de Tolbiac, 75013 Paris </addrLine> <country key="FR"></country> </address> <ref type="url">http://www.inserm.fr</ref> </desc> </org></tutelle><tutelle active="#struct-302361" type="direct"><org type="institution" xml:id="struct-302361" status="VALID"> <orgName>Groupe hospitalier Broca</orgName> <desc> <address> <country key="FR"></country> </address> </desc> </org></tutelle><tutelle active="#struct-300142" type="direct"><org type="institution" xml:id="struct-300142" status="VALID"> <orgName>Hôtel-Dieu</orgName> <desc> <address> <country key="FR"></country> </address> </desc> </org></tutelle><tutelle active="#struct-300123" type="direct"><org type="institution" xml:id="struct-300123" status="VALID"> <orgName>CHU Cochin [AP-HP]</orgName> <desc> <address> <addrLine>27 Rue du Faubourg Saint-Jacques 75014 Paris</addrLine> <country key="FR"></country> </address> </desc> </org></tutelle><tutelle active="#struct-300068" type="direct"><org type="regroupinstitution" xml:id="struct-300068" status="VALID"> <orgName>Assistance publique - Hôpitaux de Paris (AP-HP)</orgName> <orgName type="acronym">APHP</orgName> <desc> <address> <country key="FR"></country> </address> </desc> </org></tutelle></tutelles></hal:affiliation><country>France</country></affiliation></author><author><name sortKey="Hak, E" sort="Hak, E" uniqKey="Hak E" first="E" last="Hak">E. Hak</name></author><author><name sortKey="Guevara, M" sort="Guevara, M" uniqKey="Guevara M" first="M." last="Guevara">M. Guevara</name></author><author><name sortKey="Costanzo, S" sort="Costanzo, S" uniqKey="Costanzo S" first="S" last="Costanzo">S. Costanzo</name></author><author><name sortKey="Moren, A" sort="Moren, A" uniqKey="Moren A" first="A" last="Moren">A. Moren</name><affiliation wicri:level="1"><hal:affiliation type="institution" xml:id="struct-534644" status="INCOMING"> <orgName>EpiConcept [Paris]</orgName> <desc> <address> <addrLine>Paris.</addrLine> <country key="FR"></country> </address> </desc> </hal:affiliation><country>France</country></affiliation></author></analytic><series><title level="j">Eurosurveillance</title><idno type="ISSN">1560-7917</idno><imprint><date type="datePub">2015-01-15</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"> <p>While influenza vaccines aim to decrease the incidence of severe influenza among high-risk groups, evidence of influenza vaccine effectiveness (IVE) among the influenza vaccine target population is sparse. We conducted a multicentre test-negative case-control study to estimate IVE against hospitalised laboratory-confirmed influenza in the target population in 18 hospitals in France, Italy, Lithuania and the Navarre and Valencia regions in Spain. All hospitalised patients aged ≥18 years, belonging to the target population presenting with influenza-like illness symptom onset within seven days were swabbed. Patients positive by reverse transcription polymerase chain reaction for influenza virus were cases and those negative were controls. Using logistic regression, we calculated IVE for each influenza virus subtype and adjusted it for month of symptom onset, study site, age and chronic conditions. Of the 1,972 patients included, 116 were positive for influenza A(H1N1)pdm09, 58 for A(H3N2) and 232 for influenza B. Adjusted IVE was 21.3% (95% confidence interval (CI): -25.2 to 50.6; n=1,628), 61.8% (95% CI: 26.8 to 80.0; n=557) and 43.1% (95% CI: 21.2 to 58.9; n=1,526) against influenza A(H1N1) pdm09, A(H3N2) and B respectively. Our results suggest that the 2012/13 IVE was moderate against influenza A(H3N2) and B and low against influenza A(H1N1) pdm09.</p> </div></front></TEI><hal api="V3"> <titleStmt> <title xml:lang="en">2012/13 influenza vaccine effectiveness against hospitalised influenza A(H1N1)pdm09, A(H3N2) and B: estimates from a European network of hospitals.</title> <author role="aut"> <persName> <forename type="first">M</forename> <surname>Rondy</surname> </persName> <idno type="halauthorid">11383020</idno> <affiliation ref="#struct-534644"></affiliation> </author> <author role="aut"> <persName> <forename type="first">O.</forename> <surname>Launay</surname> </persName> <idno type="halauthorid">1154856</idno> <affiliation ref="#struct-232778"></affiliation> <affiliation ref="#struct-257262"></affiliation> </author> <author role="aut"> <persName> <forename type="first">J</forename> <surname>Puig-Barberà</surname> </persName> <idno type="halauthorid">11383021</idno> </author> <author role="aut"> <persName> <forename type="first">G</forename> <surname>Gefenaite</surname> </persName> <idno type="halauthorid">11383022</idno> </author> <author role="aut"> <persName> <forename type="first">J</forename> <surname>Castilla</surname> </persName> <idno type="halauthorid">11383023</idno> </author> <author role="aut"> <persName> <forename type="first">K</forename> <surname>de Gaetano Donati</surname> </persName> <idno type="halauthorid">11383024</idno> </author> <author role="aut"> <persName> <forename type="first">F.</forename> <surname>Galtier</surname> </persName> <idno type="halauthorid">205639</idno> <affiliation ref="#struct-232778"></affiliation> <affiliation ref="#struct-258773"></affiliation> <affiliation ref="#struct-196912"></affiliation> <affiliation ref="#struct-457216"></affiliation> </author> <author role="aut"> <persName> <forename type="first">E</forename> <surname>Hak</surname> </persName> <idno type="halauthorid">11383025</idno> </author> <author role="aut"> <persName> <forename type="first">M.</forename> <surname>Guevara</surname> </persName> <idno type="halauthorid">1491025</idno> </author> <author role="aut"> <persName> <forename type="first">S</forename> <surname>Costanzo</surname> </persName> <idno type="halauthorid">11383026</idno> </author> <author role="aut"> <persName> <forename type="first">A</forename> <surname>Moren</surname> </persName> <idno type="halauthorid">11383028</idno> <affiliation ref="#struct-534644"></affiliation> </author> <editor role="depositor"> <persName> <forename>Anthony</forename> <surname>Herrada</surname> </persName> <email type="md5">22bca7b7384ac878a90553705fdc7ce0</email> <email type="domain">umontpellier.fr</email> </editor> </titleStmt> <editionStmt> <edition n="v1" type="current"> <date type="whenSubmitted">2019-01-23 14:41:19</date> <date type="whenModified">2020-03-27 02:41:18</date> <date type="whenReleased">2019-01-30 15:19:47</date> <date type="whenProduced">2015-01-15</date> <date type="whenEndEmbargoed">2019-01-23</date> <ref type="file" target="https://hal.umontpellier.fr/hal-01990891/document"> <date notBefore="2019-01-23"></date> </ref> <ref type="file" subtype="greenPublisher" n="1" target="https://hal.umontpellier.fr/hal-01990891/file/art21011-en.pdf"> <date notBefore="2019-01-23"></date> </ref> </edition> <respStmt> <resp>contributor</resp> <name key="557504"> <persName> <forename>Anthony</forename> <surname>Herrada</surname> </persName> <email type="md5">22bca7b7384ac878a90553705fdc7ce0</email> <email type="domain">umontpellier.fr</email> </name> </respStmt> </editionStmt> <publicationStmt> <distributor>CCSD</distributor> <idno type="halId">hal-01990891</idno> <idno type="halUri">https://hal.umontpellier.fr/hal-01990891</idno> <idno type="halBibtex">rondy:hal-01990891</idno> <idno type="halRefHtml">Eurosurveillance, European Centre for Disease Prevention and Control, 2015, 20 (2)</idno> <idno type="halRef">Eurosurveillance, European Centre for Disease Prevention and Control, 2015, 20 (2)</idno> </publicationStmt> <seriesStmt> <idno type="stamp" n="UNIV-MONTPELLIER">Université de Montpellier</idno> <idno type="stamp" n="APHP" corresp="INSERM">AP-HP</idno> <idno type="stamp" n="UNIV-PARIS5" corresp="UNIV-PARIS">Université Paris Descartes (Paris 5)</idno> <idno type="stamp" n="USPC">Université Sorbonne Paris Cité</idno> <idno type="stamp" n="BS">Biologie-Santé</idno> <idno type="stamp" n="BC2M" corresp="UNIV-MONTPELLIER">Biocommunication en cardio-métabolique</idno> <idno type="stamp" n="UNIV-PARIS">Université de Paris</idno> </seriesStmt> <notesStmt> <note type="audience" n="2">International</note> <note type="popular" n="0">No</note> <note type="peer" n="1">Yes</note> </notesStmt> <sourceDesc> <biblStruct> <analytic> <title xml:lang="en">2012/13 influenza vaccine effectiveness against hospitalised influenza A(H1N1)pdm09, A(H3N2) and B: estimates from a European network of hospitals.</title> <author role="aut"> <persName> <forename type="first">M</forename> <surname>Rondy</surname> </persName> <idno type="halauthorid">11383020</idno> <affiliation ref="#struct-534644"></affiliation> </author> <author role="aut"> <persName> <forename type="first">O.</forename> <surname>Launay</surname> </persName> <idno type="halauthorid">1154856</idno> <affiliation ref="#struct-232778"></affiliation> <affiliation ref="#struct-257262"></affiliation> </author> <author role="aut"> <persName> <forename type="first">J</forename> <surname>Puig-Barberà</surname> </persName> <idno type="halauthorid">11383021</idno> </author> <author role="aut"> <persName> <forename type="first">G</forename> <surname>Gefenaite</surname> </persName> <idno type="halauthorid">11383022</idno> </author> <author role="aut"> <persName> <forename type="first">J</forename> <surname>Castilla</surname> </persName> <idno type="halauthorid">11383023</idno> </author> <author role="aut"> <persName> <forename type="first">K</forename> <surname>de Gaetano Donati</surname> </persName> <idno type="halauthorid">11383024</idno> </author> <author role="aut"> <persName> <forename type="first">F.</forename> <surname>Galtier</surname> </persName> <idno type="halauthorid">205639</idno> <affiliation ref="#struct-232778"></affiliation> <affiliation ref="#struct-258773"></affiliation> <affiliation ref="#struct-196912"></affiliation> <affiliation ref="#struct-457216"></affiliation> </author> <author role="aut"> <persName> <forename type="first">E</forename> <surname>Hak</surname> </persName> <idno type="halauthorid">11383025</idno> </author> <author role="aut"> <persName> <forename type="first">M.</forename> <surname>Guevara</surname> </persName> <idno type="halauthorid">1491025</idno> </author> <author role="aut"> <persName> <forename type="first">S</forename> <surname>Costanzo</surname> </persName> <idno type="halauthorid">11383026</idno> </author> <author role="aut"> <persName> <forename type="first">A</forename> <surname>Moren</surname> </persName> <idno type="halauthorid">11383028</idno> <affiliation ref="#struct-534644"></affiliation> </author> </analytic> <monogr> <idno type="halJournalId" status="VALID">863</idno> <idno type="issn">1560-7917</idno> <idno type="eissn">1025-496X</idno> <title level="j">Eurosurveillance</title> <imprint> <publisher>European Centre for Disease Prevention and Control</publisher> <biblScope unit="volume">20</biblScope> <biblScope unit="issue">2</biblScope> <date type="datePub">2015-01-15</date> </imprint> </monogr> <idno type="pubmed">25613779</idno> </biblStruct> </sourceDesc> <profileDesc> <langUsage> <language ident="en">English</language> </langUsage> <textClass> <classCode scheme="halDomain" n="sdv.mhep">Life Sciences [q-bio]/Human health and pathology</classCode> <classCode scheme="halTypology" n="ART">Journal articles</classCode> </textClass> <abstract xml:lang="en"> <p>While influenza vaccines aim to decrease the incidence of severe influenza among high-risk groups, evidence of influenza vaccine effectiveness (IVE) among the influenza vaccine target population is sparse. We conducted a multicentre test-negative case-control study to estimate IVE against hospitalised laboratory-confirmed influenza in the target population in 18 hospitals in France, Italy, Lithuania and the Navarre and Valencia regions in Spain. All hospitalised patients aged ≥18 years, belonging to the target population presenting with influenza-like illness symptom onset within seven days were swabbed. Patients positive by reverse transcription polymerase chain reaction for influenza virus were cases and those negative were controls. Using logistic regression, we calculated IVE for each influenza virus subtype and adjusted it for month of symptom onset, study site, age and chronic conditions. Of the 1,972 patients included, 116 were positive for influenza A(H1N1)pdm09, 58 for A(H3N2) and 232 for influenza B. Adjusted IVE was 21.3% (95% confidence interval (CI): -25.2 to 50.6; n=1,628), 61.8% (95% CI: 26.8 to 80.0; n=557) and 43.1% (95% CI: 21.2 to 58.9; n=1,526) against influenza A(H1N1) pdm09, A(H3N2) and B respectively. Our results suggest that the 2012/13 IVE was moderate against influenza A(H3N2) and B and low against influenza A(H1N1) pdm09.</p> </abstract> </profileDesc> </hal></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/Hal/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000117 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Hal/Checkpoint/biblio.hfd -nk 000117 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= H2N2V1
|flux= Hal
|étape= Checkpoint
|type= RBID
|clé= Hal:hal-01990891
|texte= 2012/13 influenza vaccine effectiveness against hospitalised influenza A(H1N1)pdm09, A(H3N2) and B: estimates from a European network of hospitals.
}}
| This area was generated with Dilib version V0.6.33. |  |